Alphabet is increasingly launching ‘moonshot’ projects as independent companies — here’s why

Despite the emphasis on detachment from ideas, X employees do have significant skin in the game when projects spin out.
Nature

‘Biotech Barbie’ says the time has come to consider CRISPR babies. Do scientists agree?

A company’s plan to edit the genomes of human embryos worries some researchers — but it might reflect the changing attitudes towards the controversial approach.